Enzyme PHLPP2 could be a viable drug target for treating prostate cancer
Share

(Cold Spring Harbor Laboratory) Researchers propose a new druggable target that can put a damper on the spread of prostate cancer. Containing the threat at its origin organ greatly increases the survival rates of patients who suffer from the disease.

read more...


Article originally posted at

www.eurekalert.org

Click here for the full story


Category
Tags

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD